The two main antigens for coronavirus SARS-CoV-2 are the spike (S) protein and the nucleocapsid (N) protein. The nucleocapsid protein has emerged as a better target for diagnostic antigen tests because it’s more conserved, and it’s more abundant.
Unlike many tests out there, RTP Supplies’ MöLab and Healgen COVID-19 Rapid Antigen Test detects the nucleocapsid protein making it a far more accurate and dependable test.
The Coronavirus Rapid AG Test:
Relative Sensitivity: 97.3%
Relative Specificity: >99.9%
Accuracy: 99%
MöLab GmbH was established in 1983. For more than 37 years, the company has been pioneering new and modern ways to manufacture point-of-care diagnostics in Germany. Their products and services serve doctors, hospitals, utilities, public institutions, and security-related authorities all across Europe.
The Healgen COVID-19 Rapid Antigen test is also fully approved by the UK government, one of only three such tests to achieve this status, and it is therefore widely used by local authorities, education settings and businesses right across Europe. The tests are also CE marked and are included on a list of tests considered appropriate for use by the European Union. In order to have qualified for this list, the tests must:
- Carry a CE approval mark
- Perform at a minimum of ≥ 90% sensitivity and ≥ 97% specificity
- Validated as appropriate for their use in the context of COVID-19 by at least one Member State
Therefore, all of the test kits we carry for sale are highly accurate and approved for use. You can find our product certifications here.